Is There a Role for MACOP-B in the Treatment of Diffuse Large Cell Lymphoma?
作者:
O'reillySusan E.,
ConnorsJoseph M.,
期刊:
Leukemia&Lymphoma
(Taylor Available online 1993)
卷期:
Volume 10,
issue sup1
页码: 85-89
ISSN:1042-8194
年代: 1993
DOI:10.3109/10428199309149118
出版商: Taylor&Francis
关键词: Diffuse large cell lymphoma;MACOP-B
数据来源: Taylor
摘要:
Between 1981 and 1986, 126 patients with advanced stage, large cell lymphoma were treated with MACOP-B chemotherapy. Their six-year failure-free and overall survival is 52% and 62% respectively. Eighty-eight patients aged 60 or less had an excellent six year overall survival of 68%. The outcome for various subsets of patients is analysed according to the number of adverse prognostic factors including age, stage, lactic dehydrogenase level and number of extra nodal sites.
点击下载:
PDF (295KB)
返 回